Please login to the form below

Not currently logged in
Email:
Password:

Hans Lennernas joins board of CMO Recipharm

He is currently professor of biopharmaceuticals at Uppsala University

Sweden-based contract manufacturing organisation (CMO) Recipharm has appointed Professor Hans Lennernäs to its board of directors.

Prof Lennernäs is currently a professor of biopharmaceuticals at Uppsala University in Sweden, where he manages an Innovative Medicines Initiative (IMI) project called OrBiTo, which aims to improve the delivery of oral drugs.

Other industry experience includes serving as principle investigator in a collaborative project between US drug regulator the FDA, the University of Michigan and the Medical Product Agency in Sweden to develop a new guideline for the biopharmaceuticals classification systems.

Prof Lennernäs has also helped to launch several life sciences companies, including DuoCort Pharma and LIDDS.

“We are very pleased to welcome a board member of Hans Lennernäs calibre,” said Maria Lundberg, manager of Recipharm, which supplies pharma companies with products such as solid dose medicines, granulates and powders, sterile liquids and lyophilisates, hormones, oral liquids, sprays and dry powder inhalers.

“His track record of successfully inventing and developing several novel drug delivery systems that are currently in pre-clinical phase and in preparation for phase I, II and III clinical trials, makes him an excellent addition to the board.”

6th February 2013

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Escaping the spin cycle of sub-optimal launch
...

Infographics